Palmar lactic acid linked to pathogen defense - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Palmar lactic acid linked to pathogen defense

  • By

  • Andrea Surnit

  • November 20, 2026

  • 4 min

Share

Clinical Scorecard: Palmar lactic acid linked to pathogen defense

At a Glance

CategoryDetail
ConditionClinical topic addressed by the source article: Palmar lactic acid linked to pathogen defense
Key MechanismsMechanisms or clinical associations described in the source article.
Target PopulationPatients or participants described in the source article.
Care SettingCross-sectional skin assessment and laboratory testing of palmar surface extracts; the study did not establish effects on intact skin or pathogen transmission.

Key Highlights

  • Higher palmar lactic acid was associated with lower hand-scaling scores (Spearman r = −0.63).
  • Greater in vitro pathogen-inactivation activity was associated with less scaling for influenza A/H3N2 (r = −0.57), S aureus (r = −0.49), and E coli (r = −0.41).
  • Lactic acid remained positively associated with activity against all three pathogens in partial correlation analyses accounting for skin pH and temperature; it also remained associated in separate models incorporating hand scaling, sweat rate, and skin pH.
  • Total ceramide and total amino acid content were not significantly associated with scaling; three ceramide classes showed significant inverse associations.
  • The cross-sectional design and laboratory assays using extracts cannot establish whether modifying palmar lactic acid improves skin condition or reduces pathogen transmission.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          The study included 49 healthy adults aged 20 to 49 years; it did not evaluate a treatment or prescribing intervention.

          The findings do not establish that modifying palmar lactic acid improves skin condition or reduces pathogen transmission.

          Clinical Best Practices

          • The source reports that the cross-sectional design prevents causal inference and that the small sample may limit detection of weaker associations and generalizability.
          • The source notes that laboratory assays using extracted skin components do not establish effects on intact skin or pathogen transmission.
          • The source identifies potential confounders including moisturizer use, environmental and occupational exposures, hand hygiene, dermatologic conditions, and skin microbiome composition.

          Related Resources & Content

          Original Source(s)

          Related Content